FDA Releases Forward-Looking Report on Inspections

On May 5, FDA released a report titled “Resiliency Roadmap for FDA Inspectional Oversight,” explaining how FDA adjusted its inspection program during the COVID-19 pandemic and providing details on its priorities moving forward. In March 2020, FDA responded to COVID-19 by postponing all domestic and foreign routine facility inspections, only resuming prioritized domestic inspections in... Continue Reading